- Home
- AGO vs BHVN Comparison
AGO vs BHVN Comparison
Compare AGO & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGO
- BHVN
- Stock Information
- Founded
- AGO 2003
- BHVN 2013
- Country
- AGO Bermuda
- BHVN United States
- Employees
- AGO N/A
- BHVN N/A
- Industry
- AGO Property-Casualty Insurers
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- AGO Finance
- BHVN Health Care
- Exchange
- AGO Nasdaq
- BHVN Nasdaq
- Market Cap
- AGO 4.5B
- BHVN 4.2B
- IPO Year
- AGO 2004
- BHVN 2017
- Fundamental
- Price
- AGO $89.85
- BHVN $36.85
- Analyst Decision
- AGO Buy
- BHVN Strong Buy
- Analyst Count
- AGO 3
- BHVN 14
- Target Price
- AGO $103.33
- BHVN $63.15
- AVG Volume (30 Days)
- AGO 222.1K
- BHVN 725.9K
- Earning Date
- AGO 02-27-2025
- BHVN 03-03-2025
- Dividend Yield
- AGO 1.51%
- BHVN N/A
- EPS Growth
- AGO 73.00
- BHVN N/A
- EPS
- AGO 13.02
- BHVN N/A
- Revenue
- AGO $867,000,000.00
- BHVN N/A
- Revenue This Year
- AGO N/A
- BHVN N/A
- Revenue Next Year
- AGO N/A
- BHVN $154.39
- P/E Ratio
- AGO $6.92
- BHVN N/A
- Revenue Growth
- AGO N/A
- BHVN N/A
- 52 Week Low
- AGO $72.57
- BHVN $26.80
- 52 Week High
- AGO $96.60
- BHVN $62.21
- Technical
- Relative Strength Index (RSI)
- AGO 42.17
- BHVN 40.96
- Support Level
- AGO $90.21
- BHVN $38.40
- Resistance Level
- AGO $92.60
- BHVN $42.82
- Average True Range (ATR)
- AGO 1.66
- BHVN 2.14
- MACD
- AGO -0.42
- BHVN -0.16
- Stochastic Oscillator
- AGO 7.61
- BHVN 0.34
About AGO Assured Guaranty Ltd.
Assured Guaranty Ltd. provides credit protection products to the United States and international public finance and structured finance markets, and manages assets across collateralized loan obligations as well as opportunity funds and liquid funds that build on its corporate credit, asset-based finance, municipal and healthcare experience. The company is operating in two segments Insurance segment and the Asset Management segment. The majority of the revenue earned by the company from the Insurance segment.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.